Refeyn

Drug development depends on understanding how individual molecules behave, but traditional analysis methods are slow, complex, and often disruptive.

Refeyn has developed a new class of instruments based on mass photometry, a technology that measures the mass of single molecules in solution – quickly, accurately, and without labels. Spun out of Oxford, its tools have been used in more than 1,100 papers so far and are helping scientists streamline R&D to unlock faster, deeper insights in biotherapeutics and beyond.